Clinical Trial Update: COVID-19: A Pilot Study of Adaptive Immunity and Anti-PD1 [Phase 2]

View source ↗

Summary

Phase 2 pilot trial investigating adaptive immunity and anti-PD1 for COVID-19 (SARS-CoV-2). Status not specified.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sars-cov-2

Drugs mentioned

• Anti-PD1

Snippet

Sponsor: Dr Gerry Gin Wai Kwok | Conditions: COVID-19, SARS-CoV-2 | Phase 2 | Status: UNKNOWN